YZ
Yanan Zhu Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$3.04B
| $27 | $45 |
67%
upside
| Overweight | 13 days ago |
|
2
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $82 |
34%
upside
| Overweight | 16 days ago |
|
3
Taysha Gene Therapies
TSHA
$917M
| $3.36 | $8 |
138%
upside
| Overweight | 25 days ago |
|
|
AUTL
4
Autolus Therapeutics
AUTL
$389M
| $1.46 | $5 |
242%
upside
| Overweight | 25 days ago |
|
5
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $42 |
135%
upside
| Overweight | 26 days ago |
|
6
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $14 |
462%
upside
| Overweight | 1 month ago |
|
7
Intellia Therapeutics
NTLA
$1.29B
| $12.06 | $45 |
273%
upside
| Overweight | 1 month ago |
|
8
Avidity Biosciences
RNA
$6.48B
| $50.36 | $75 |
49%
upside
| Overweight | 1 month ago |
|
9
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $50 |
167%
upside
| Overweight | 1 month ago |
|
10
Beam Therapeutics
BEAM
$2.11B
| $20.88 | $70 |
235%
upside
| Overweight | 4 months ago |
|
11
uniQure
QURE
$985M
| $17.95 | $30 |
67%
upside
| Equal-Weight | 6 months ago |
|
12
Spyre Therapeutics
SYRE
$1.03B
| $17 | $40 |
135%
upside
| Overweight | 1 year ago |
|
13
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $65 |
18%
upside
| Equal-Weight | 1 year ago |
|
14
enGene Holdings
ENGN
$265M
| $5.18 | $30 |
479%
upside
| Overweight | 1 year ago |
|
|
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $16.80 | $24 |
43%
upside
| Overweight | 2 years ago |
|
16
argenx
ARGX
$45.9B
| $750.78 | $326 |
57%
downside
| Equal-Weight | 4 years ago |
|